FDA approves oral version of Wegovy

The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight-loss pill, the first such supplement approved for use. Novo Nordisk said in a Tuesday release that the GLP-1 pill is intended for once-daily use to “reduce excess body weight and maintain weight reduction long-term and to reduce the risk…